Cargando…

Cell Therapy in Chagas Disease

Chagas disease which is caused by the parasite Trypanosoma cruzi is an important cause of cardiomyopathy in Latin America. In later stages chagasic cardiomyopathy is associated with congestive heart failure which is often refractory to medical therapy. In these individuals heart transplantation has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campos de Carvalho, Antonio C., Goldenberg, Regina C. S., Jelicks, Linda A., Soares, Milena B. P., dos Santos, Ricardo Ribeiro, Spray, David C., Tanowitz, Herbert B.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2009
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696023/ https://www.ncbi.nlm.nih.gov/pubmed/19547703 http://dx.doi.org/10.1155/2009/484358

Ejemplares similares

Mesenchymal Bone Marrow Cell Therapy in a Mouse Model of Chagas Disease. Where Do the Cells Go?
por: Jasmin,, et al.
Publicado: (2012)

Perspectives on Adipose Tissue, Chagas Disease and Implications for the Metabolic Syndrome
por: Nagajyothi, Fnu, et al.
Publicado: (2009)

Pathogenesis of Chagas Cardiomyopathy: Role of Inflammation and Oxidative Stress
por: Machado, Fabiana S., et al.
Publicado: (2013)

Chagas' disease and AIDS
por: Vaidian, Anil K, et al.
Publicado: (2004)

Chagas Disease Has Now Gone Global
por: Tanowitz, Herbert B., et al.
Publicado: (2011)

Aspirin Treatment of Mice Infected with Trypanosoma cruzi and Implications for the Pathogenesis of Chagas Disease
por: Mukherjee, Shankar, et al.
Publicado: (2011)

Coronary Microvascular Disease in Chronic Chagas Cardiomyopathy Including an Overview on History, Pathology, and Other Proposed Pathogenic Mechanisms
por: Rossi, Marcos A., et al.
Publicado: (2010)

The Einstein-Brazil Fogarty: A decade of synergy
por: Nosanchuk, Joshua D., et al.
Publicado: (2015)

Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy
por: Santos, Emanuelle de Souza, et al.
Publicado: (2021)

Correction: optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging
por: Jasmin, et al.
Publicado: (2011)

Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging
por: Jasmin, et al.
Publicado: (2011)

Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy
por: Silva, Daniela Nascimento, et al.
Publicado: (2014)

IGF-1-Overexpressing Mesenchymal Stem/Stromal Cells Promote Immunomodulatory and Proregenerative Effects in Chronic Experimental Chagas Disease
por: Silva, Daniela N., et al.
Publicado: (2018)

Assessment of speckle tracking strain predictive value for myocardial fibrosis in subjects with Chagas disease
por: Macedo, Carolina Thé, et al.
Publicado: (2015)

Assessment of Galectin-3 Polymorphism in Subjects with Chronic Chagas Disease
por: Cruz, Gabriela da Silva, et al.
Publicado: (2015)

Parasitic Diseases, Diagnostic Approaches, and Therapies
por: Tanowitz, Herbert B., et al.
Publicado: (2009)

High Fat Diet Modulates Trypanosoma cruzi Infection Associated Myocarditis
por: Nagajyothi, Fnu, et al.
Publicado: (2014)

Chagas Disease in the New York City Metropolitan Area
por: Zheng, Crystal, et al.
Publicado: (2020)

The Presence and Extension of Myocardial Fibrosis in the Undetermined Form of Chagas’ Disease: A Study Using Magnetic Resonance
por: Noya-Rabelo, Marcia Maria, et al.
Publicado: (2018)

A novel substrate for arrhythmias in Chagas disease
por: Santos-Miranda, Artur, et al.
Publicado: (2021)

Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy
por: Nonaka, Carolina Kymie Vasques, et al.
Publicado: (2019)

Endothelin-1 Mediates Brain Microvascular Dysfunction Leading to Long-Term Cognitive Impairment in a Model of Experimental Cerebral Malaria
por: Freeman, Brandi D., et al.
Publicado: (2016)

Acute Chagas disease in the state of Pará, Amazon Region: is it increasing?
por: dos Santos, Valéria Regina Cavalcante, et al.
Publicado: (2018)

Granulocyte-Colony Stimulating Factor-Overexpressing Mesenchymal Stem Cells Exhibit Enhanced Immunomodulatory Actions Through the Recruitment of Suppressor Cells in Experimental Chagas Disease Cardiomyopathy
por: Silva, Daniela N., et al.
Publicado: (2018)

Lack of association between serum syndecan-4, myocardial fibrosis and ventricular dysfunction in subjects with chronic Chagas disease
por: Larocca, Ticiana Ferreira, et al.
Publicado: (2017)

Efficacy and Safety of Granulocyte-Colony Stimulating Factor Therapy in Chagas Cardiomyopathy: A Phase II Double-Blind, Randomized, Placebo-Controlled Clinical Trial
por: Macedo, Carolina T., et al.
Publicado: (2022)

Therapeutic miR-21 Silencing Reduces Cardiac Fibrosis and Modulates Inflammatory Response in Chronic Chagas Disease
por: Nonaka, Carolina Kymie Vasques, et al.
Publicado: (2021)

Electrophysiological characteristics of Chagas disease
por: Cedraz, Swellen Schuenemann, et al.
Publicado: (2013)

Galectin-3 Knockdown Impairs Survival, Migration, and Immunomodulatory Actions of Mesenchymal Stromal Cells in a Mouse Model of Chagas Disease Cardiomyopathy
por: Souza, Bruno Solano de Freitas, et al.
Publicado: (2017)

TriatoScore: an entomological-risk score for Chagas disease vector control-surveillance
por: Ribeiro-Jr, Gilmar, et al.
Publicado: (2021)

Therapeutic effects of sphingosine kinase inhibitor N,N-dimethylsphingosine (DMS) in experimental chronic Chagas disease cardiomyopathy
por: Vasconcelos, Juliana Fraga, et al.
Publicado: (2017)

Disruption of Calcium Homeostasis in Cardiomyocytes Underlies Cardiac Structural and Functional Changes in Severe Sepsis
por: Celes, Mara R. N., et al.
Publicado: (2013)

Chagas disease treatment: a 120-year-old challenge to public health
por: Goldenberg, Samuel
Publicado: (2022)

Treatment of Chagas Cardiomyopathy
por: Botoni, Fernando A., et al.
Publicado: (2013)

Tolerogenic Dendritic Cells Reduce Cardiac Inflammation and Fibrosis in Chronic Chagas Disease
por: Santos, Emanuelle de Souza, et al.
Publicado: (2020)

Trypanosoma cruzi Promotes Transcriptomic Remodeling of the JAK/STAT Signaling and Cell Cycle Pathways in Myoblasts
por: Nisimura, Lindice M., et al.
Publicado: (2020)

Cognitive dysfunction in chronic Chagas disease cardiomyopathy
por: Dias, Jesângeli Sousa, et al.
Publicado: (2009)

Screening for Chagas disease from the electrocardiogram using a deep neural network
por: Jidling, Carl, et al.
Publicado: (2023)

Heart Rate Variability and Chagas Heart Disease
por: Almeida-Santos, Marcos Antonio, et al.
Publicado: (2015)

Potential Role of Antioxidants as Adjunctive Therapy in Chagas Disease
por: Sánchez-Villamil, Juana P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rnoealii81f2qociq3h1fao7tn